Class information for:
Level 1: SOLUBLE CD30//SCD30//CD30

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17012 558 37.5 90%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
914 10549 CD40//BAFF//CD40 LIGAND

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOLUBLE CD30 Author keyword 81 83% 8% 45
2 SCD30 Author keyword 46 70% 7% 38
3 CD30 Author keyword 44 29% 23% 128
4 CD30 LIGAND Author keyword 28 81% 3% 17
5 CD30L Author keyword 13 62% 2% 13
6 SGN 35 Author keyword 3 39% 1% 7
7 CD153 Author keyword 3 100% 1% 3
8 SOLUBLE CD30 SCD30 Author keyword 3 100% 1% 3
9 SCD26 Author keyword 3 50% 1% 4
10 BER H2 Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SOLUBLE CD30 81 83% 8% 45 Search SOLUBLE+CD30 Search SOLUBLE+CD30
2 SCD30 46 70% 7% 38 Search SCD30 Search SCD30
3 CD30 44 29% 23% 128 Search CD30 Search CD30
4 CD30 LIGAND 28 81% 3% 17 Search CD30+LIGAND Search CD30+LIGAND
5 CD30L 13 62% 2% 13 Search CD30L Search CD30L
6 SGN 35 3 39% 1% 7 Search SGN+35 Search SGN+35
7 CD153 3 100% 1% 3 Search CD153 Search CD153
8 SOLUBLE CD30 SCD30 3 100% 1% 3 Search SOLUBLE+CD30+SCD30 Search SOLUBLE+CD30+SCD30
9 SCD26 3 50% 1% 4 Search SCD26 Search SCD26
10 BER H2 2 67% 0% 2 Search BER+H2 Search BER+H2

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOLUBLE CD30 69 63% 13% 70
2 SCD30 37 100% 3% 14
3 KI 1 ANTIGEN 34 63% 6% 35
4 HIGH SERUM LEVEL 10 73% 1% 8
5 ANTI CD30 MONOCLONAL ANTIBODY 9 43% 3% 17
6 PRETRANSPLANT SOLUBLE CD30 9 59% 2% 10
7 TH2 TYPE CYTOKINES 8 30% 4% 24
8 CD30 LIGAND 8 33% 3% 19
9 POSTTRANSPLANT SCD30 6 80% 1% 4
10 HIV EXPRESSION 6 44% 2% 11

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Deciphering CD30 ligand biology and its role in humoral immunity 2006 60 79 73%
CD30-targeted antibody therapy 2011 24 43 72%
CD30: an important new target in hematologic malignancies 2011 28 110 52%
CD30: expression and function in health and disease 1998 138 117 57%
Brentuximab Vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies 2012 27 41 29%
CD30 in normal and neoplastic cells 1999 83 97 61%
The role of CD30 in atopic disease 2001 36 94 63%
Posttransplant sCD30 as a biomarker to predict kidney graft outcome 2012 2 18 94%
Soluble CD30 serum level - an adequate marker for allograft rejection of solid organs? 2007 12 62 81%
Role of CD30(+) T cells in rheumatoid arthritis: a counterregulatory paradigm for Th1-driven diseases 2001 49 89 36%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ADV IMMUNOL 1 20% 0.9% 5
2 DEV ONCOL HEMATOL LEUKEMIA UNIT 1 40% 0.4% 2
3 CANC SCI SOUTHAMPTON GEN HOSP 1 50% 0.2% 1
4 CHAIR CARDIAC SURG TRANSPLANTOL 1 50% 0.2% 1
5 DIPARTIMENTO MED INTERNA CARDIONAGIOL EPATOL 1 50% 0.2% 1
6 EXPT PATHOL IMMUNOTHER Y 1 50% 0.2% 1
7 IMMUNOL CLIN ALERGIA 1 50% 0.2% 1
8 KATEDRA ZAKLAD IMMUNOL SEROL 1 50% 0.2% 1
9 REFERENCIA VIROL 1 50% 0.2% 1
10 SECT INTERNAL MED ONCOL SCI CLIN EXPT ME 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000229855 ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//NPM ALK
2 0.0000217643 IMMUKNOW//IMMUNE FUNCTION ASSAY//CYLEX IMMUKNOW ASSAY
3 0.0000124219 HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA
4 0.0000109012 TAK1//TRAF4//TRAF5
5 0.0000106971 4 1BB//OX40//CD137
6 0.0000089226 ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1
7 0.0000085111 CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE
8 0.0000066104 HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA
9 0.0000046694 DERRIFORD COMBINED S//CYTOKINE GENE POLYMORPHISM//CLINICIZZATA CHIRURG 2
10 0.0000041525 KEMEROVO SCI//04KA//ADD ORGAN OPERAT